Last Updated: June 24, 2026

Bulk Pharmaceutical API Sources for imipramine pamoate

✉ Email this page to a colleague

Bulk Pharmaceutical API Sources for imipramine pamoate

Subscribe to access the full database, or Start Trial
Vendor	Vendor Homepage	Vendor Sku	API Url
NovoSeek	⤷ Start Trial	24904	⤷ Start Trial
ABI Chem	⤷ Start Trial	AC1L2NRC	⤷ Start Trial
Clearsynth	⤷ Start Trial	CS-P-06966	⤷ Start Trial
Smolecule	⤷ Start Trial	S597302	⤷ Start Trial
THE BioTek	⤷ Start Trial	bt-372134	⤷ Start Trial
Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.	⤷ Start Trial	PH-1917CE	⤷ Start Trial
BOC Sciences	⤷ Start Trial	10075-24-8	⤷ Start Trial
>Vendor	>Vendor Homepage	>Vendor Sku	>API Url

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.